Progyny Inc at Credit Suisse Healthcare Conference Transcript
© -
Welcome to the Credit Suisse Healthcare Conference. With us today I have Progyny. I'm Jonathan Yong, the healthcare technology analyst here.
With us today, we have CEO, Pete Anevski; and CFO, Mark Livingston. And in the audience, we also have James Hart from IR. So thank you for attending and participating here, guys.
Questions & Answers
© -
So, I guess, just to jump right into it. You guys reported 3Q results recently. Can you give us just a quick summary of how the results came in relative to your expectations and how things are trajecting?
Yes. Our results were very strong in the third quarter. We reported revenues of $205 million, which was a 68% increase over the prior year, and our adjusted EBITDA was $35 million, which was actually over 100% growth over the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
